P aperN o.____
`D ate filed :September28 ,2017
`
`Filed O n B ehalf O f:
`N ovartis A G
`
`B y:
`N icholas N .Kallas
`N Kallas@ fchs.com
`ZortressA finitorIP R@ fchs.com
`(212)218 -2100
`
`UN ITE D S TA TE S P A TE N T A N D TRA D E M A RK O FFIC E
`
`B EFO RE TH E P A TEN T TRIA L A N D A P P EA L B O A RD
`
`P A R P H A RM A C EUTIC A L ,IN C .,
`A RGEN TUM P H A RM A C EUTIC A L L L C ,A N D
`W EST-W A RD P H A RM A C EUTIC A L S
`IN TERN A TIO N A L L IM ITED
`P etitioners,
`
`v.
`
`N O V A RTIS A G,
`P atentO wner.
`
`C ase IP R2016-0147 91
`P atentN o.9,006,224
`
`UN O P P O S E D N O TIC E O FTRA N S C RIP TIO N E RRO RS
`
`1 A rgentu m P harmaceu ticalL L C was joined as apartyto this proceed ingviaa
`M otion forJoind erin IP R2017 -01063;W est-W ard P harmaceu ticals International
`L imited was joined as apartyviaaM otion forJoind erin IP R2017 -0107 8 .
`
`
`D ate filed :September28 ,2017
`
`Filed O n B ehalf O f:
`N ovartis A G
`
`B y:
`N icholas N .Kallas
`N Kallas@ fchs.com
`ZortressA finitorIP R@ fchs.com
`(212)218 -2100
`
`UN ITE D S TA TE S P A TE N T A N D TRA D E M A RK O FFIC E
`
`B EFO RE TH E P A TEN T TRIA L A N D A P P EA L B O A RD
`
`P A R P H A RM A C EUTIC A L ,IN C .,
`A RGEN TUM P H A RM A C EUTIC A L L L C ,A N D
`W EST-W A RD P H A RM A C EUTIC A L S
`IN TERN A TIO N A L L IM ITED
`P etitioners,
`
`v.
`
`N O V A RTIS A G,
`P atentO wner.
`
`C ase IP R2016-0147 91
`P atentN o.9,006,224
`
`UN O P P O S E D N O TIC E O FTRA N S C RIP TIO N E RRO RS
`
`1 A rgentu m P harmaceu ticalL L C was joined as apartyto this proceed ingviaa
`M otion forJoind erin IP R2017 -01063;W est-W ard P harmaceu ticals International
`L imited was joined as apartyviaaM otion forJoind erin IP R2017 -0107 8 .
`
`
`
`P aperN o.____
`D ate filed :September28 ,2017
`P u rsu antto the B oard ’s emails of September22,2017 and September25,
`
`2017 (Ex.2116),P atentO wnerN ovartis A G su bmits this u nopposed notice of
`
`transcription errors in the transcriptfrom the A u gu st28 ,2017 d eposition of D r.
`
`M arkJ.Ratain (Ex.2111),id entifyingthe errors in Ex.2111 bypage and line
`
`nu mber,and where,if atall,those portions of the transcriptare cited in P atent
`
`O wner’s Su r-Reply(P aper26)orO bservations on C ross-Examination of D r.
`
`Ratain (P aper34).A s ind icated in P atentO wner’s emailrequ estto the B oard ,
`
`P atentO wnerand P etitionerP arP harmaceu tical,Inc.have conferred and agreed
`
`u pon the listof transcription errors thatshou ld be corrected in Ex.2111.Ex.2116.
`
`C ited In The Record
`P aper34,p.6,line 6
`
`To
`P age:L ine From
`6115
`14:22
`615
`an
`26:20
`in the
`carcinoid tu mors
`27 :3
`carcinoid s,tu mors
`reports
`27 :19
`report
`32:4
`eyelet--witheyelet islet--withislet
`41:2
`of
`have
`46:9
`D oxetaxel
`D ocetaxel
`7 2:23
`tu mor
`tu mors
`7 3:25-
`an end ocrine
`neu roend ocrine
`7 4:2
`8 1:19
`8 3:6
`8 4:9
`8 4:20
`8 7 :4
`8 7 :16
`97 :3
`
`111:23
`
`1
`
`pu t
`pop
`an
`a
`somatostatin
`metastatic
`somatostatin
`metastatic
`cancerorlymphomas
`cancerlymphomas
`cancerlymphoma cancerorlymphoma
`pharmacod ynamic
`pharmacod ynamic-
`gu id e
`gu id ed stu d y
`membrane,not
`membrane wou ld not P aper34,p.4,line 1
`P aper34,p.4,line 8
`
`P aper26,p.1,line 17
`P aper26,p.2,line 6
`
`P aper34,p.7 ,line 14
`
`
`
`P age:L ine From
`114:23
`B cl-2
`119:6
`forms
`120:11
`the metabolites
`121:17
`5-fu
`125:13
`5-fu
`126:10
`5-fu
`133:3
`are
`134:8
`response
`
`To
`B C L 2
`form
`antimetabolites
`5-FU
`5-FU
`5-FU
`on
`volu me
`
`137 :23
`153:20
`161:13
`17 6:14
`17 6:24
`17 7 :23
`17 8 :13
`17 8 :19
`17 8 :24
`18 4:13
`201:2
`201:15
`203:5
`
`D oes
`inventor
`galenical
`rad iant3
`rad iant3
`rad iant3
`rad iant3
`rad iant3
`rad iant3
`cells,d oesn’t
`rad iant3
`d ataone
`“d espite limitations
`the need to stu d y
`
`statements
`203:15
`207 :10-11 rad iant3
`209:2-3
`rad iant3
`209:8
`rad iant3
`210:11-12 rad iant3
`211:5
`experience P N ETs
`218 :2
`d ru g
`218 :16
`5-fu
`218 :21
`batalanib
`220:25
`researches
`222:17
`sand ostatin
`222:20
`sand ostatin
`227 :5
`O ctreoThu r
`
`Itd oes
`inventors
`galenic
`RA D IA N T-3
`RA D IA N T-3
`RA D IA N T-3
`RA D IA N T-3
`RA D IA N T-3
`RA D IA N T-3
`cells,itd oesn’t
`RA D IA N T-3
`d ata.O ne
`“d espite the
`limitations in
`interstu d y
`treatmentsettings
`RA D IA N T-3
`RA D IA N T-3
`RA D IA N T-3
`RA D IA N T-3
`experience in P N ETs
`stu d y
`5-FU
`vatalanib
`researchers
`Sand ostatin
`Sand ostatin
`O ctreoTher
`
`2
`
`P aperN o.____
`D ate filed :September28 ,2017
`C ited In The Record
`P aper34,p.4,line 20
`
`P aper34,p.3,line 12
`P aper34,p.3,line 12
`
`P aper34,p.7 ,line 8
`P aper34,p.6,n.1,
`line 4
`
`P aper26,p.5,line 3
`
`P aper34,p.6,line 14
`P aper34,p.6,line 14
`P aper34,p.6,line 14
`
`P aper34,p.9,line 19
`P aper34,p.9,line 13
`P aper34,p.9,line 13
`P aper34,p.9,line 13
`
`
`
`P aperN o.____
`D ate filed :September28 ,2017
`C ited In The Record
`
`P aper26,p.2,lines 13-
`14
`
`P age:L ine From
`227 :14
`O ctreoThu r
`233:24
`ratcarcinoma
`
`To
`O ctreoTher
`carcinoma
`
`235:10
`238 :8
`242:18
`250:2
`254:3
`257 :20
`264:23
`269:9
`
`P d x1
`a-amylase
`line and
`process
`&
`chloroazod in
`solelyonly
`pharmaceu tical
`have
`
`P D X 1
`alpha-amylase
`line,an
`prognosis
`as
`chlorozotocin
`solely
`pharmaceu tical
`ind u stryhave
`
`D ated :September28 ,2017
`
`Respectfu llysu bmitted ,
`
`/N icholas N .Kallas /
`N icholas N .Kallas
`Registration N o.31,530
`L ead C ou nselforP atentO wner
`FITZP A TRIC K,C EL L A ,H A RP ER
`& SC IN TO
`1290 A venu e ofthe A mericas
`N ew Y ork,N Y 10104-38 00
`Tel.212-218 -2100
`
`3
`
`
`
`P aperN o.____
`D ate filed :September28 ,2017
`
`C E RTIFIC A TE O FS E RV IC E
`
`Icertifythatacopyof the foregoingUnopposed N otice of Transcription
`
`Errors was served on September28 ,2017 bycau singitto be sentbyemailto
`
`cou nselforP etitioners atthe followingemailad d resses:
`
`D anielG.B rown (d aniel.brown@ lw.com)
`
`Jonathan M .Strang(jonathan.strang@ lw.com)
`
`B rend aL .D anek(brend a.d anek@ lw.com)
`
`Kevin L au rence (klau rence@ lpiplaw.com)
`
`M atthew P hillips (mphillips@ lpiplaw.com)
`
`TylerC .L iu (tliu @ agpharm.com)
`
`KeithA .Zu llow (kzu llow@ good winprocter.com)
`
`M artaE.D elsignore (md esignore@ good winprocter.com)
`
`D ated :September28 ,2017
`
`/N icholas N .Kallas /
`N icholas N .Kallas
`Registration N o.31,530
`L ead C ou nselforP atentO wner
`FITZP A TRIC K,C EL L A ,H A RP ER
`& SC IN TO
`1290 A venu e ofthe A mericas
`N ew Y ork,N Y 10104-38 00
`Tel.212-218 -2100
`
`1
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
